Story

American Healthcare REIT Shares Decline Following $712 Million Stock Offering

ENTHMSVIIDZHZH-TWJAKOHI
Aug 11, 20262 min read
American Healthcare REIT Shares Decline Following $712 Million Stock Offering
Text size
Background

Shares of American Healthcare REIT (AHR) declined in pre-market trading on Tuesday after the real estate investment trust announced the pricing of a substantial secondary stock offering. The move, aimed at raising capital for acquisitions, is creating downward pressure on the stock price due to the dilutive effect on existing shares.

Offering Details

The company priced an underwritten public offering of 13,250,000 shares of its common stock, according to a company announcement late Monday. The offering is structured through forward sale agreements and is expected to generate aggregate gross proceeds of approximately $712.2 million before expenses.

Key details of the transaction include:

  • The offering is being jointly managed by Morgan Stanley, Citigroup, and KeyBanc Capital Markets.
  • Underwriters have a 30-day option to purchase up to an additional 1,987,500 shares.
  • American Healthcare REIT intends to use the net proceeds to fund a pending acquisition of a senior housing properties portfolio, as well as for future investments and general corporate purposes.

Market Reaction

Sample IUX Markets – In-articleAd

Following the news, AHR stock was trading down 4.5% to $53 per share in pre-open activity. This type of sell-off is a typical market reaction to secondary offerings, as the increase in the number of shares outstanding dilutes the ownership stake of existing shareholders.

The decline appears to be company-specific, as the broader U.S. equity markets were trading modestly higher. The source noted the S&P 500 was up 0.2%, indicating that macroeconomic factors were not driving the weakness in AHR's stock.

Analyst Perspective

Despite the offering-related pressure, some analysts view the company's underlying fundamentals as solid. Following strong second-quarter results, analysts at Citizens reiterated a Market Outperform rating and a $65 price target on AHR.

The company's normalized Funds From Operations (FFO) for the second quarter was $0.54 per share, which exceeded both the firm's and consensus estimates. While the capital raise is causing short-term price pressure, it is strategically aimed at funding acquisitions consistent with the REIT's growth strategy.

Read next

More on Stocks
Back to latest news

LATEST